Detection of GLP-1 in joint fluid suggests hormone-based drugs may impact inflammation in arthritis. Researchers highlight ...
Use of certain glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly increased risk for new-onset rheumatoid arthritis (RA), particularly with shorte ...